Newly appointed Benchmark CFO Septima Maguire joins the company today.
Maguire, appointed in September, will work through a transition period with exiting CFO Mark Plampin become taking the CFO reins with effect from Dec. 18.
Maguire joins Benchmark from Dechra Pharmaceuticals, a FTSE 250 international provider of specialist veterinary pharmaceuticals and related products, where she spent four years.
Having joined as group financial controller she was acting group finance director between 2016 and 2017.
She was most recently corporate development director overseeing all aspects of acquisition activities, strategic projects, business development and investment initiatives playing a significant role in supporting the company during a period of high growth.